WIRE — India has approved its first vaccine to help prevent dengue, marking a significant step in tackling one of the countrys most widespread mosquito-borne diseases. Japanese biopharmaceutical company Takeda on Monday announced that its dengue vaccine, QDENGA, has received market authorisation from the Drug Controller General of India (DCGI).
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.